Universal Health Services (NYSE:UHS) posts Q3 2026 sales in line with estimates
Universal Health Services (UHS) reported Q3 2026 revenue of $4.73 billion, matching estimates and showing 5.3% year-on-year growth. Adjusted EPS beat estimates at $5.22, while adjusted EBITDA missed at $624.6 million. Operating margin declined to 9.6% from 11.6% year-on-year, but free cash flow margin improved to 8.9% from 3.4%. Same-store sales rose 4.7% year-on-year, up from 2% in the prior year quarter.
How this was made
The 30-second read
Why it matters
The earnings release provides fresh data on revenue growth, profitability, and cash generation, which are key inputs for valuation models and short‑term trading decisions.
Market read
UHS earnings are the primary catalyst for the article, offering actionable insight for traders in the healthcare sector.
What to watch
The rise in same‑store sales (4.7% YoY) and improved free cash flow margin (8.9%) may support longer‑term upside.
Background
Universal Health Services (UHS) is a leading provider of acute care and behavioral health services in the United States.
Ticker impact
Universal Health Services reported Q3 2026 revenue of $4.73B in line with estimates, EPS beat, but EBITDA missed expectations.
potential modest downside pressure as the market prices in the EBITDA miss despite the EPS beat
The beat on adjusted EPS is modest (1.3%) while adjusted EBITDA fell short (1.6% miss) and operating margin declined, suggesting investors may focus on the profit margin weakness.
Market effects
Healthcare services sector may see scrutiny on margin trends across peers.
U.S. healthcare stocks could experience slight volatility in the post‑market session.
Limited to U.S. markets; no immediate global ripple.
Counterpoint
Investors could view the EPS beat as a sign of pricing power and buy on dip despite margin pressure.
Key entities
- companyUniversal Health Services
U.S. healthcare services operator reporting Q3 2026 results.
